This section of the FEDERAL REGISTER contains documents other than rules or proposed rules that are applicable to the public. Notices of hearings and investigations, committee meetings, agency decisions and rulings, delegations of authority, filing of petitions and applications and agency statements of organization and functions are examples of documents appearing in this section. 

# Notices Federal Register 

### 49409

Vol. 77, No. 159

Thursday, August 16, 2012

1 To view the notice, the comments we received, the EA, and the FONSI, go to http://www. regulations.gov/#!docketDetail;D=APHIS-2012-
0052. **DEPARTMENT OF AGRICULTURE**

**Agricultural Research Service**

**Notice of Intent To Grant Exclusive License** 

**AGENCY :**  Agricultural Research Service, USDA.

**ACTION :**  Notice of intent.

**SUMMARY :**  Notice is hereby given that the U.S. Department of Agriculture, Agricultural Research Service, intends to grant to the University of Mississippi of University, Mississippi, an exclusive license to U.S. Patent Application Serial No. 13/463,442, ‘‘Anti-Obesity Properties of Pterostilbene’’, filed on May 3, 2012.

**DATES :**  Comments must be received on or before September 17, 2012.

**ADDRESSES :**  Send comments to: USDA, ARS, Office of Technology Transfer, 5601 Sunnyside Avenue, Rm. 4–1174, Beltsville, Maryland 20705–5131.

**FOR FURTHER INFORMATION CONTACT :**  June Blalock of the Office of Technology Transfer at the Beltsville address given above; telephone: 301–504–5989.

**SUPPLEMENTARY INFORMATION :**  The Federal Government’s patent rights in this invention are assigned to the United States of America, as represented by the Secretary of Agriculture. The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within thirty (30) days from the date of this published Notice, the Agricultural Research Service receives written evidence and argument which establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7.

Richard J. Brenner,
Assistant Administrator.
[FR Doc. 2012–20126 Filed 8–15–12; 8:45 am]

**BILLING CODE 3410–03–P**

**DEPARTMENT OF AGRICULTURE**

**Animal and Plant Health Inspection Service** 

**[Docket No. APHIS–2012–0052]**

**Oral Rabies Vaccine Trial; Availability of an Environmental Assessment and**  **Finding of No Significant Impact**

**AGENCY :**  Animal and Plant Health Inspection Service, USDA.

**ACTION :**  Notice.

**SUMMARY :**  We are advising the public that the Animal and Plant Health Inspection Service has prepared an environmental assessment and finding of no significant impact relative to an oral rabies vaccination field trial in New Hampshire, New York, Ohio, Vermont, and West Virginia. Based on its finding of no significant impact, the Animal and Plant Health Inspection Service has determined that an environmental impact statement need not be prepared.

**FOR FURTHER INFORMATION CONTACT :**  Mr. Richard Chipman, Rabies Program Coordinator, Wildlife Services, APHIS, 59 Chennell Drive, Suite 7, Concord, NH 03301; (603) 223–9623. To obtain copies of the environmental assessment or finding of no significant impact, contact Ms. Beth Kabert, Environmental Coordinator, Wildlife Services, 140–C Locust Grove Road, Pittstown, NJ 08867; (908) 735–5654, fax (908) 735–0821, email: beth.e.kabert@aphis.usda.gov.

**SUPPLEMENTARY INFORMATION :**  Background

The Wildlife Services (WS) program in the Animal and Plant Health Inspection Service (APHIS) cooperates with Federal agencies, State and local governments, and private individuals to research and implement the best methods of managing conflicts between wildlife and human health and safety, agriculture, property, and natural resources. Wildlife-borne diseases that can affect domestic animals and humans are among the types of conflicts that APHIS–WS addresses. Wildlife is the dominant reservoir of rabies in the United States.

On July 9, 2012, we published in the Federal Register (77 FR 40322–40323, Docket No. APHIS–2012–0052) a notice 1 in which we announced the availability, for public review and comment, of an environmental assessment (EA) that examined the potential environmental impacts associated with the proposed field trial to test the safety and efficacy of an experimental oral rabies vaccine for wildlife in New Hampshire, New York, Ohio, Vermont, and West Virginia.

We solicited comments on the EA for 30 days ending August 8, 2012. We received nine comments by that date. They were from private citizens (including five comments from the same individual), a foreign government, a Federal agency, and a State department of health. Three commenters expressed support for the proposed field trial. One commenter indicated we should prepare an environmental impact statement rather than an EA for this action but did not provide a reason for doing so. Other issues raised by commenters include concerns regarding possible effects on public health and whether the field trial is necessary. The comments, and APHIS’ responses to the comments, are presented in an appendix to the EA (see footnote 1).

In this document, we are advising the public of our finding of no significant impact (FONSI) regarding the implementation of a field trial to test the safety and efficacy of the AdRG1.3 wildlife rabies vaccine in New Hampshire, New York, Ohio, Vermont, and West Virginia, including portions of U.S. Department of Agriculture (USDA) Forest Service National Forest System lands, but excluding Wilderness Areas. The finding, which is based on the EA, reflects our determination that the distribution of this experimental wildlife rabies vaccine will not have a significant impact on the quality of the human environment.

The EA and FONSI may be viewed on the APHIS Web site at http://www. aphis.usda.gov/regulations/ws/ws

_ nepa

_environmental

_ documents.shtml and on the Regulations.gov Web site (see footnote 1). Copies of the EA and